Advances and new strategies for the treatment of chronic hepatitis B
CHENG QI
SHI Guang-feng
Abstract：Treatment of chronic hepatitis B (CHB) has markedly improved in recent years due to the development of direct-acting antiviral agents. According to some problems in clinical practice, such as suboptimal response and drug resistance, the indications of antiviral treatment, primary drug choices and endpoints of therapy have been updated and revised. Moreover, some new drugs are being developed to target different mechanisms. This review focuses on the advances and new strategies for the treatment of CHB.
Keywords：hepatitis Bchronicinterferonsnucleosidesdrug resistanceviralmolecular targeted therapyimmunotherapy
Publication Date：2016-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 109-112 )